Centre for Infection and Immunity, Health Sciences Building, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.
BMC Med. 2013 Aug 20;11:166. doi: 10.1186/1741-7015-11-166.
Despite its high incidence and devastating outcomes, acute respiratory distress syndrome (ARDS) has no specific treatment, with effective therapy currently limited to minimizing potentially harmful ventilation and avoiding a positive fluid balance. Many pharmacological therapies have been investigated with limited success to date. In this review article we provide a state-of-the-art update on recent and ongoing trials, as well as reviewing promising future pharmacological therapies in ARDS.
尽管急性呼吸窘迫综合征 (ARDS) 的发病率很高，后果严重，但目前尚无特效治疗方法，有效的治疗方法仅限于尽量减少潜在的有害通气和避免正液平衡。迄今为止，许多药物治疗方法的研究都取得了有限的成功。在这篇综述文章中，我们提供了最新的近期和正在进行的试验的最新进展，并回顾了 ARDS 中有前途的未来药物治疗方法。
